Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid A Mayer

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Journal of Cancer Survivorship : Research and Practice|July 25, 2019
Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot studyJennifer N Vega, Kimberly M Albert, Ingrid A Mayer, et al.
Cancer Research|December 4, 2020
Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast CancerFei Wang, Wei Zheng, Christina E Bailey, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell CarcinomaErica Nakajima, Paul Leger, Ingrid A Mayer, et al.
International Journal of Cancer|August 25, 2020
Radiotherapy after breast-conserving surgery for elderly patients with early-stage breast cancer: A national registry-based studyFei Wang, Ingrid Meszoely, Tuya Pal, et al.
Scientific Reports|April 8, 2017
A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapyJun Qian, Heidi Chen, Xiangming Ji, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 9, 2022
FGFR1 Antibody Validation and Characterization of FGFR1 Protein Expression in ER+ Breast CancerPaula I Gonzalez-Ericsson, Alberto Servetto, Luigi Formisano, et al.
Plos One|April 13, 2012
Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective studyMingxuan Xie, Xiangzhu Zhu, Zhaofan Liu, et al.
Clinical Breast Cancer|April 3, 2020
Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and ToxicityAlexander D Sherry, Ingrid A Mayer, Diandra N Ayala-Peacock, et al.
Journal of Gastrointestinal Oncology|February 4, 2014
Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility studyNise H Yamaguchi, Ingrid A Mayer, Artur Malzyner, et al.
International Journal of Molecular Sciences|June 2, 2021
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast CancerChi Yan, Jinming Yang, Nabil Saleh, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Journal of Cancer Survivorship : Research and Practice|July 25, 2019
Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot studyJennifer N Vega, Kimberly M Albert, Ingrid A Mayer, et al.
Cancer Research|December 4, 2020
Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast CancerFei Wang, Wei Zheng, Christina E Bailey, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell CarcinomaErica Nakajima, Paul Leger, Ingrid A Mayer, et al.
International Journal of Cancer|August 25, 2020
Radiotherapy after breast-conserving surgery for elderly patients with early-stage breast cancer: A national registry-based studyFei Wang, Ingrid Meszoely, Tuya Pal, et al.
Scientific Reports|April 8, 2017
A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapyJun Qian, Heidi Chen, Xiangming Ji, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 9, 2022
FGFR1 Antibody Validation and Characterization of FGFR1 Protein Expression in ER+ Breast CancerPaula I Gonzalez-Ericsson, Alberto Servetto, Luigi Formisano, et al.
Plos One|April 13, 2012
Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective studyMingxuan Xie, Xiangzhu Zhu, Zhaofan Liu, et al.
Clinical Breast Cancer|April 3, 2020
Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and ToxicityAlexander D Sherry, Ingrid A Mayer, Diandra N Ayala-Peacock, et al.
Journal of Gastrointestinal Oncology|February 4, 2014
Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility studyNise H Yamaguchi, Ingrid A Mayer, Artur Malzyner, et al.
International Journal of Molecular Sciences|June 2, 2021
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast CancerChi Yan, Jinming Yang, Nabil Saleh, et al.
Pageof 15